Simvastatin Attenuated Tumor Growth in Different Pancreatic Tumor Animal Models
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Newly diagnosed pancreatic cancer increases year by year, while the prognosis of pancreatic cancer has not been very good. Statin drugs were found to have protective effects against a variety of cancers, but their association with pancreatic cancer remains to be clarified. This study used different pancreatic cancer cell lines and in different animal models to confirm the relationship between simvastatin and pancreatic cancer. Flow cytometry and luciferase-based bioluminescent images were used to investigate the cell cycle and tumor growth changes under simvastatin treatment. Simvastatin decreased the MIA PaCa-2 cells, PANC-1 cells, and BxPC-3 cell viability significantly and may arrest the cell cycle in the G0 phase. During in vivo study, subcutaneously implanted simvastatin pre-treated pancreatic cancer cells and intraperitoneally treated simvastatin continuously demonstrated a slower tumor growth rate and decreased the tumor/body weight ratio significantly. In intravenous implant models, implanted simvastatin-pre-treated BxPC-3 cells and cells treated along with simvastatin significantly decreased the tumor growth curve. Implanting the simvastatin-pre-treated pancreatic cells in the subcutaneous model showed better growth inhibition than the intravenous model. These results suggest simvastatin treatment may relate to different signaling pathways in local growth and metastasis. Pancreatic cancer cells presented different growth patterns in different animal-induced models, which could be important for clinical reference when it comes to the relationship of long-term statin use and pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The simvastatin-induced growth inhibition persisted after simvastatin-exposed cells were implanted in mice: subcutaneous, intraperitoneal and intravenous”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Chen et al., 2022
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“simvastatin decreased the viability of PDAC cells in cell lines such as MIA PaCa-2 cells, PANC-1 cells, and BxPC-3 by G0 cell cycle arrest”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Chen et al., 2022
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Rawla, P., Sunkara, T., & Gaduputi, V. (2019) · World Journal of Oncology · doi:10.14740/wjon1166 · Cited by 2,269
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Analysis of mortality rates for pancreatic cancer across the world
Hariharan, D., Saied, A., & Kocher, H. M. (2008) · HPB · doi:10.1080/13651820701883148 · Cited by 335
Statin use and cancer risk: a comprehensive review
Boudreau, D. M., Yu, O., & Johnson, J. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740331003662620 · Cited by 274
The Pathology and Genetics of Metastatic Pancreatic Cancer
Yachida, S., & Iacobuzio-Donahue, C. A. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.3.413 · Cited by 269
Statin Induces Apoptosis and Cell Growth Arrest in Prostate Cancer Cells
Hoque, A., Chen, H., & Xu, X.-C. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0531 · Cited by 206
Cho, S., Kim, J. S., Kim, J. M., Lee, J. Y., Jung, H. C., & Song, I. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23593 · Cited by 195
Walter, F. M., Mills, K., Mendonça, S. C., Abel, G. A., Basu, B., Carroll, N., Ballard, S., Lancaster, J., Hamilton, W., Rubin, G. P., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30079-6 · Cited by 174
Bond-Smith, G., Banga, N., Hammond, T. M., & Imber, C. J. (2012) · BMJ · doi:10.1136/bmj.e2476 · Cited by 160
Hong, J. Y., Nam, E. M., Lee, J., Park, J. O., Lee, S., Song, S.-Y., Choi, S. H., Heo, J. S., Park, S. H., Lim, H. Y., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2328-1 · Cited by 134
Arora, S., Bhardwaj, A., Srivastava, S. K., Singh, S., McClellan, S., Wang, B., & Singh, A. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021573 · Cited by 134
Therapy Insight: potential of statins for cancer chemoprevention and therapy
Katz, M. S. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0097 · Cited by 129
Simvastatin suppresses breast cancer cell proliferation induced by senescent cells
Liu, S., Uppal, H., Demaria, M., Desprez, P.-Y., Campisi, J., & Kapahi, P. (2015) · Scientific Reports · doi:10.1038/srep17895 · Cited by 124 · cited 1×
“Previous studies have shown that statins have anti-tumor effects on many types of cancers, such as colon [23], breast [24], and prostate cancer [25].”
BackgroundStatin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study
Chiu, H., Ho, S., Chen, C., & Yang, C. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.475 · Cited by 121
Self-citationThe potential use of simvastatin for cancer treatment: A review
Duarte, J. A., de Barros, A. L. B., & Leite, E. A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111858 · Cited by 118
Inhibition of pancreatic adenocarcinoma cell growth by lovastatin
Sumi, S., Beauchamp, R. D., Townsend, C. M., Uchida, T., Murakami, M., Rajaraman, S., Ishizuka, J., & Thompson, J. C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90032-t · Cited by 107
Gao, Z., Wang, J., Chen, D.-H., Ma, X., Wu, Y., Tang, Z., & Dang, X. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0192-0 · Cited by 101
Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer
Huang, B. Z., Chang, J. I., Li, E., Xiang, A. H., & Wu, B. U. (2017) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw275 · Cited by 75
Jian‐Yu, E., Graber, J. M., Lu, S., Lin, Y., Lu‐Yao, G. L., & Tan, X. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170412145232 · Cited by 71
Kowalski, S., Hać, S., Wyrzykowski, D., Zauszkiewicz–Pawlak, A., & Inkielewicz‐Stępniak, I. (2017) · Oncotarget · doi:10.18632/oncotarget.19454 · Cited by 57
Fujiwara, D., Tsubaki, M., Takeda, T., Tomonari, Y., Koumoto, Y., Sakaguchi, K., & Nishida, S. (2017) · Tumor Biology · doi:10.1177/1010428317734947 · Cited by 57
Gong, J., Sachdev, E., Robbins, L. A., Lin, E., Hendifar, A. E., & Mita, M. M. (2017) · Oncology Letters · doi:10.3892/ol.2017.5572 · Cited by 54
Variability in statin-induced changes in gene expression profiles of pancreatic cancer
Gbelcová, H., Rimpelová, S., Ruml, T., Fenclová, M., Kosek, V., Hajšlová, J., Strnad, H., Kolář, M., & Vítek, L. (2017) · Scientific Reports · doi:10.1038/srep44219 · Cited by 48
Fendrich, V., Sparn, M. B., Lauth, M., Knoop, R. F., Plaßmeier, L., Bartsch, D. K., & Waldmann, J. (2013) · Pancreatology · doi:10.1016/j.pan.2013.08.002 · Cited by 39
Differences of statin activity in 2D and 3D pancreatic cancer cell cultures
Paškevičiūtė, M., & Petrikaitė, V. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s149411 · Cited by 36
Pitavastatin suppressed liver cancer cells in vitro and in vivo
Zhang, W.-J., You, H.-Y., Xie, X.-M., Zheng, Z.-H., Zhu, H.-L., & Jiang, F.-Z. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s106906 · Cited by 36
Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7
Afzali, M., Vatankhah, M., & Ostad, S. N. (2016) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.146127 · Cited by 36
Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency
Jung, H. H., Lee, S. H., Kim, J., Ahn, J. S., Park, Y. H., & Im, Y. (2016) · Scientific Reports · doi:10.1038/srep33035 · Cited by 35
In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
Fujita, M., Hasegawa, A., Yamamori, M., & Okamura, N. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0557-6 · Cited by 34
Shan, L., Wang, S., Korotcov, A. V., Sridhar, R., & Wang, P. C. (2008) · PubMed · Cited by 20
Self-citationAntitumor effects of the combination of cholesterol reducing drugs
Issat, T. (2011) · Oncology Reports · doi:10.3892/or.2011.1261 · Cited by 13
Xu, P., Xia, X., Yang, Z., Tian, Y., Di, J., & Guo, M. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4940 · Cited by 13
Zhu, Q., Pan, X., Sun, Y., Wang, Z., Liu, F., Li, A., Zhao, Z., Wang, Y., Li, K., & Mi, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185507 · Cited by 11
Evaluation of Tumor Cell Response to Hyperthermia with Bioluminescent Imaging.
Zhang, R., Zhou, Y., Wang, P. C., & Sridhar, R. (2012) · PubMed · Cited by 2
Self-citation
Research works printed but not linked: 2
- PDQ® Adult Treatment Editorial Board (2022, November 13). PDQ Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment. Bethesda, MD: National Cancer Institute. Updated <10/07/2022>. PMID: 26389340, Available online: https://www.cancer.gov/types/pancreatic/patient/pnet-treatment-pdq.
- PDQ® Adult Treatment Editorial Board (2022, November 13). PDQ Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment. Bethesda, MD: National Cancer Institute. Updated <8/19/2022>. PMID: 26389309, Available online: https://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq.
Cited by
Zhou, X., Li, Y., Yang, C., Chen, D., Wang, T., Liu, T., Yan, W., Su, Z., Peng, B., & Ren, X. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121698 · Cited by 32
The role of statins in the regulation of breast and colorectal cancer and future directions
Dang, Y., Zhang, Y., & Wang, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1578345 · Cited by 17
Statins and Cancer: A Complex Relationship Worth Exploring
Bil, J. (2023) · Pharmaceuticals · doi:10.3390/ph16111570 · Cited by 6
Miao, H., Zhang, B., Li, Y., Ma, X., Yang, Y., Lin, Z., & Liu, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111753 · Cited by 5
Self-citationWang, Z., Wu, D. P., Zhang, Y. ‐., 陈卫波, Fan, S., Yang, Y., Yang, Y., Zu, G., An, Y., Jin, Y., et al. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01164-y · Cited by 2
Self-citation
Metadata
- Authors
- Chen, C.-Y., Yang, Y.-F., Wang, P. C., Shan, L., Lin, S., Chen, P.-J., Chen, Y.-J., Chiang, H.-S., Lin, J.-T., Hung, C.-F., & Liang, Y.-J.
- Affiliations
- Fu Jen Catholic University (TW)
- Howard University (US)
- Corresponding author
- Liang, Yao-Jen
- ORCID
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2022-11-14
- Volume
- 15
- Issue
- 11
- Pages
- 1408
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC9692350
- OpenAlex
- W4309032583
- Cited by
- 13
- References
- 37
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 1 · 2023: 2
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (NIH/NIMHD G12MD007597, NSC MOST—105—2632—B—030—001)
- Taiwan National Science and Technology Council (NIH/NIMHD G12MD007597, NSC MOST—105—2632—B—030—001)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- simvastatin, pancreatic cancer, statins, tumor growth inhibition, cell cycle arrest, MIA PaCa-2 cells, PANC-1 cells, BxPC-3 cells, subcutaneous xenograft, intraperitoneal implantation, metastasis, anticancer effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.